Kiora Pharmaceuticals (KPRX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.40, -0.41% vs the prior close of $2.41.
- Volume 11.89K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
KPRX dips 0.4% to $2.40, a 3-month low, 4 down days in a row. Closed at $2.40, -0.41% vs the prior close of $2.41. Day range $2.36–$2.42, opened at $2.42.
KPRX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — KPRX dips 0.4% to $2.40, a 3-month low, 4 down days in a row
- Closed at $2.40, -0.41% vs the prior close of $2.41. Day range $2.36–$2.42, opened at $2.42.
- Volume was 11.89K shares, 0.8x its 50-day average of 14.86K.
- Price is -7.2% vs its 50-day average ($2.59) and -0.4% vs its 200-day average ($2.41).
- 52-week range $1.76–$2.91; today's close sits at 55% of that range, 17.5% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 — KPRX dips 2.4% to $2.41, a 3-month low, 3 down days in a row
- Closed at $2.41, -2.43% vs the prior close of $2.47. Day range $2.35–$2.46, opened at $2.46.
- Volume was 25.40K shares, 1.7x its 50-day average of 14.70K.
- Price is -6.9% vs its 50-day average ($2.59) and +0.1% vs its 200-day average ($2.41).
- 52-week range $1.76–$2.91; today's close sits at 56% of that range, 17.2% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — KPRX ends flat (+0.0%) to $2.47
- Closed at $2.47, +0.00% vs the prior close of $2.47. Day range $2.45–$2.49, opened at $2.47.
- Volume was 18.30K shares, 1.2x its 50-day average of 15.14K.
- Price is -4.7% vs its 50-day average ($2.59) and +2.7% vs its 200-day average ($2.40).
- 52-week range $1.76–$2.91; today's close sits at 62% of that range, 15.1% below the 52-week high.
Oct 13, 2026 — KPRX slides 3.5% to $2.47, a 1-month low
- Closed at $2.47, -3.52% vs the prior close of $2.56. Day range $2.47–$2.55, opened at $2.55.
- Volume was 3.00K shares, 0.2x its 50-day average of 15.21K — lighter than usual.
- Price is -4.7% vs its 50-day average ($2.59) and +2.8% vs its 200-day average ($2.40).
- 52-week range $1.76–$2.91; today's close sits at 62% of that range, 15.1% below the 52-week high.
Oct 12, 2026 — KPRX rises 0.8% to $2.56
- Closed at $2.56, +0.79% vs the prior close of $2.54. Day range $2.52–$2.56, opened at $2.53.
- Volume was 12.80K shares, 0.9x its 50-day average of 15.05K.
- Price is -1.3% vs its 50-day average ($2.59) and +6.7% vs its 200-day average ($2.40).
- 52-week range $1.76–$2.91; today's close sits at 69% of that range, 12.0% below the 52-week high.
Oct 9, 2026 — KPRX rises 0.4% to $2.54
- Closed at $2.54, +0.40% vs the prior close of $2.53. Day range $2.52–$2.57, opened at $2.52.
- Volume was 4.50K shares, 0.3x its 50-day average of 15.05K — lighter than usual.
- Price is -2.1% vs its 50-day average ($2.59) and +5.9% vs its 200-day average ($2.40).
- 52-week range $1.76–$2.91; today's close sits at 68% of that range, 12.7% below the 52-week high.
Oct 8, 2026 — KPRX ends flat (+0.0%) to $2.53
- Closed at $2.53, +0.00% vs the prior close of $2.53. Day range $2.48–$2.54, opened at $2.52.
- Volume was 24.30K shares, 1.7x its 50-day average of 14.66K.
- Price is -2.5% vs its 50-day average ($2.60) and +5.6% vs its 200-day average ($2.40).
- 52-week range $1.76–$2.95; today's close sits at 65% of that range, 14.2% below the 52-week high.
Oct 7, 2026 — KPRX rises 1.2% to $2.53
- Closed at $2.53, +1.20% vs the prior close of $2.50. Day range $2.49–$2.54, opened at $2.51.
- Volume was 21.00K shares, 1.4x its 50-day average of 14.50K.
- Price is -2.5% vs its 50-day average ($2.60) and +5.7% vs its 200-day average ($2.39).
- 52-week range $1.76–$2.95; today's close sits at 65% of that range, 14.2% below the 52-week high.
Oct 6, 2026 — KPRX dips 1.2% to $2.50, 3 down days in a row
- Closed at $2.50, -1.19% vs the prior close of $2.53. Day range $2.50–$2.62, opened at $2.52.
- Volume was 20.20K shares, 1.4x its 50-day average of 14.16K.
- Price is -3.7% vs its 50-day average ($2.60) and +4.5% vs its 200-day average ($2.39).
- 52-week range $1.76–$2.95; today's close sits at 62% of that range, 15.3% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — KPRX dips 1.2% to $2.53
- Closed at $2.53, -1.17% vs the prior close of $2.56. Day range $2.52–$2.57, opened at $2.56.
- Volume was 8.60K shares, 0.5x its 50-day average of 16.60K — lighter than usual.
- Price is -2.6% vs its 50-day average ($2.60) and +5.9% vs its 200-day average ($2.39).
- 52-week range $1.76–$2.95; today's close sits at 65% of that range, 14.2% below the 52-week high.
Oct 2, 2026 — KPRX dips 0.8% to $2.56
- Closed at $2.56, -0.78% vs the prior close of $2.58. Day range $2.55–$2.56, opened at $2.55.
- Volume was 3.40K shares, 0.2x its 50-day average of 16.68K — lighter than usual.
- Price is -1.5% vs its 50-day average ($2.60) and +7.2% vs its 200-day average ($2.39).
- 52-week range $1.76–$2.95; today's close sits at 67% of that range, 13.2% below the 52-week high.
KPRX latest news & SEC filings
Every SEC filing by or about KPRX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 17, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 17, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 19, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 7, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$2.08M (prior year -$2.15M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.34 (prior year -$0.54) (loss narrowed vs Jun 30, 2025)
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade KPRX
- Last results release: Aug 7, 2026 (8-K Item 2.02). Previous ones: May 8, 2026, Mar 25, 2026, Nov 7, 2025. Based on that rhythm, the next report is likely around Nov 6, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.45% (largest 3.5%).
- Liquidity: about 11.58K shares (≈$27.80K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.40 vs a range of $1.76–$2.91 (55% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 8, 2026; 8-K Aug 19, 2026; 8-K Aug 7, 2026.
- Share count: 4.42M shares outstanding (Aug 5, 2026), +28.9% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
KPRX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.42 | 2.42 | 2.36 | 2.40 | 11.89K |
| Oct 15, 2026 | 2.46 | 2.46 | 2.35 | 2.41 | 25.40K |
| Oct 14, 2026 | 2.47 | 2.49 | 2.45 | 2.47 | 18.30K |
| Oct 13, 2026 | 2.55 | 2.55 | 2.47 | 2.47 | 3.00K |
| Oct 12, 2026 | 2.53 | 2.56 | 2.52 | 2.56 | 12.80K |
| Oct 9, 2026 | 2.52 | 2.57 | 2.52 | 2.54 | 4.50K |
| Oct 8, 2026 | 2.52 | 2.54 | 2.48 | 2.53 | 24.30K |
| Oct 7, 2026 | 2.51 | 2.54 | 2.49 | 2.53 | 21.00K |
| Oct 6, 2026 | 2.52 | 2.62 | 2.50 | 2.50 | 20.20K |
| Oct 5, 2026 | 2.56 | 2.57 | 2.52 | 2.53 | 8.60K |
| Oct 2, 2026 | 2.55 | 2.56 | 2.55 | 2.56 | 3.40K |
| Oct 1, 2026 | 2.57 | 2.58 | 2.56 | 2.58 | 16.80K |
| Sep 30, 2026 | 2.57 | 2.57 | 2.56 | 2.56 | 2.40K |
| Sep 29, 2026 | 2.63 | 2.64 | 2.58 | 2.60 | 6.70K |
| Sep 28, 2026 | 2.62 | 2.67 | 2.62 | 2.67 | 6.70K |
| Sep 25, 2026 | 2.62 | 2.63 | 2.60 | 2.63 | 2.40K |
| Sep 24, 2026 | 2.63 | 2.67 | 2.58 | 2.67 | 19.40K |
| Sep 23, 2026 | 2.73 | 2.75 | 2.62 | 2.62 | 10.10K |
| Sep 22, 2026 | 2.70 | 2.80 | 2.63 | 2.71 | 7.60K |
| Sep 21, 2026 | 2.75 | 2.75 | 2.62 | 2.68 | 6.20K |
About Kiora Pharmaceuticals
Kiora Pharmaceuticals (KPRX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in ENCINITAS, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1372514.
KPRX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| David Hollander | Director | Jun 12, 2026 |
| Erin Parsons | Director | Jun 12, 2026 |
| Aron Shapiro | Director | Jun 12, 2026 |
| Carmine N. Stengone | Director | Jun 12, 2026 |
| Brian M. Strem | President and CEO | Jul 2, 2026 |
| Praveen Tyle | Director | Jun 12, 2026 |
| Lisa Walters-Hoffert | Director | Jun 12, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Eric Joseph Daniels | Chief Development Officer | Apr 2, 2026 |
| Brian M. Strem | President and CEO | Jul 2, 2026 |
| Melissa Tosca | CFO | Jul 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
KPRX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-10.84M | -2.64 | $-9.96M |
| Dec 31, 2024 | — | $3.59M | 0.87 | $8.56M |
| Dec 31, 2023 | — | $-12.51M | -24.25 | $-9.56M |
| Dec 31, 2022 | — | $-13.58M | -18.55 | $-10.43M |
| Dec 31, 2021 | $0 | $-13.77M | -57.12 | $-10.68M |
Latest balance sheet: total assets $23.78M, total liabilities $6.92M, cash $7.08M (as of Jun 30, 2026).
KPRX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 7, 2026 | 8-K Item 2.02 (results) | $2.64 |
| May 8, 2026 | 8-K Item 2.02 (results) | $2.45 |
| Mar 25, 2026 | 8-K Item 2.02 (results) | $2.04 |
| Nov 7, 2025 | 8-K Item 2.02 (results) | $2.33 |
| Aug 8, 2025 | 8-K Item 2.02 (results) | $2.36 |
| May 9, 2025 | 8-K Item 2.02 (results) | $3.25 |
| Mar 25, 2025 | 8-K Item 2.02 (results) | $3.04 |
| Nov 8, 2024 | 8-K Item 2.02 (results) | $3.53 |
| Aug 9, 2024 | 8-K Item 2.02 (results) | — |
| May 10, 2024 | 8-K Item 2.02 (results) | — |
| Mar 25, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on KPRX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.